A practical approach to managing patients with HCV infection

Area of Science:

• Hepatology
• Virology
• Public Health

Background:

• Hepatitis C virus (HCV) infection presents a significant global health challenge, contributing to chronic liver disease and hepatocellular carcinoma (HCC).
• Accurate diagnostic tools, including HCV antibody and RNA testing, are crucial for identifying infected individuals.
• Understanding the natural history and disease progression is vital for effective management strategies.

Purpose of the Study:

• To review the diagnostic modalities for Hepatitis C virus (HCV) infection.
• To outline current therapeutic options for chronic HCV and their response rates.
• To emphasize the importance of evaluating treatment candidacy for optimal patient outcomes.

Main Methods:

• Review of diagnostic studies for HCV antibody and RNA detection.
• Analysis of current standard therapy regimens, including pegylated interferon and ribavirin.
• Evaluation of treatment response rates across different HCV genotypes (1, 2, and 3).

Main Results:

• HCV antibody and RNA tests provide highly accurate diagnoses.
• Standard therapy yields response rates of approximately 40% for genotype 1 and 80% for genotypes 2 and 3.
• Successful treatment can halt liver disease progression, reduce transplantation needs, and potentially lower HCC risk.

Conclusions:

• Effective management of chronic HCV infection requires understanding its natural history, diagnostic methods, and therapeutic options.
• Careful evaluation of treatment candidacy is essential for personalized patient care.
• Current treatments offer significant benefits in preventing severe liver disease complications.